Telehealth is Only as Good as the Bandwidth in Many Critical Cases

Telehealth is no good if there is a poor connection. We have all heard the static, robot voices and watched a frozen screen. Network, internet, and bandwidth are all words patients and doctors are familiar with, but in the end, it only matters if they can communicate. Nearly 50 million people live in rural areas as defined by the CDC as non-urban.

People in remote and rural areas lack access to high-level care and specialists putting them at 50% higher risk of death from unintentional accidents, stroke, and respiratory disease. Nautilus Medical is solving these issues in telehealth with a technology called TeleRay. This platform delivers better connections and quality by utilizing peer to peer connections and high-speed cellular networks when bandwidth is low.

On Telehealth: Timothy Kelley, CEO of Nautilus, said “Our rural and mobile doctors and professionals can use TeleRay in many situations.” He explained that TeleRay could view modalities such as ultrasound in real-time from remote locations. He said, “Emergency responders, maternal-fetal medicine doctors, cardiologists, and more can view the patient, the modality, and speak to the sonographer or technologist to get results that matter.” Ultrasounds can determine internal bleeding, injuries, and fractures miles away.

There are multiple medical situations where a specialist or higher-level professional must view images or consult in how they are acquired. COVID 19 has added to the triage issues in receiving patients, and remote lung sweeps with an ultrasound would help enable a more efficient intake of critical patients and where they can go in the hospital before arrival.

Nautilus Medical CTO Cody Neville likes to talk about the platform’s advantages, including the storage, sharing, and access to images after they are captured. “This gives immediate access with real-time tools to make a diagnosis from anywhere on any device.” He continued, “Its prime time for a platform like this that combines telehealth with radiology, TeleRay is the only platform that offers real-time viewing of the modalities which can be critical in high-risk situations where a specialist can virtually look over the shoulder of the sonographer or technologist as if they’re in the room to adjust, view, and consult.”

The financial benefits to complete telehealth platforms are immense. Beyond the clinical and triage benefits, implementing a virtual care option can help offset the decline in revenue due to reduced visits. Since 80% of all primary care visits do not need physical interaction, the efficiency of a 15-minute visit can be much better with fewer exam rooms and fewer parking requirements.

The main issue is making sure the connection is high-quality speed and access to additional data and images. Good quality helps ensure better outcomes, which is the goal of healthcare visits.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”